Glucose in urine — known medically as glucosuria or glycosuria — is a finding that can arise for several reasons, from undiagnosed diabetes to normal physiological changes in pregnancy. Under healthy conditions, the kidneys reabsorb virtually all filtered glucose back into the bloodstream, so its presence in urine is clinically significant. Whether detected during a routine antenatal check, a GP consultation, or a home test, glucosuria always warrants further investigation. This article explains what glucose in urine means, its common causes, how it is diagnosed in the UK, when to seek medical advice, and what treatment or monitoring may follow.

What Does Glucose in Urine Mean?

Glucose in urine (glucosuria) means the kidneys are excreting glucose that has not been reabsorbed, typically because blood glucose has exceeded the renal threshold of approximately 10 mmol/L, though a lowered renal threshold — as in pregnancy or renal glucosuria — can also be responsible.

Glucose in urine — medically termed glucosuria or glycosuria — refers to the presence of detectable levels of glucose (sugar) in a urine sample. Under normal physiological conditions, the kidneys filter glucose from the blood and reabsorb virtually all of it back into the bloodstream, meaning that urine should contain little to no glucose. When glucose does appear in urine, it typically signals that something has disrupted this reabsorption process.

The kidneys have a renal threshold for glucose, which sits at approximately 10 mmol/L of blood glucose in most adults. When blood glucose rises above this threshold — as can occur in diabetes mellitus — the renal tubules become saturated and can no longer reabsorb all the filtered glucose, causing it to spill into the urine. It is important to note that this threshold varies between individuals and is often lower during pregnancy, meaning that glucosuria can occur in pregnant women whose blood glucose is entirely normal. This is known as physiological glycosuria of pregnancy and is distinct from gestational diabetes.

Glucosuria does not always indicate high blood sugar; in some cases, the kidneys themselves may be less efficient at reabsorbing glucose even when blood glucose levels are normal.

Finding glucose in urine is therefore a clinical indicator that warrants further investigation rather than an immediate diagnosis in itself. It may be discovered incidentally during a routine urine dipstick test — for example, during an antenatal check, a pre-employment medical, or a GP consultation for an unrelated concern. It is worth noting that dipstick results can be affected by certain factors: very dilute urine may produce a false negative, whilst high concentrations of ascorbic acid (vitamin C) can interfere with the glucose oxidase reagent and reduce the apparent result. An isolated trace result should ideally be rechecked using a fresh, first-morning urine sample and confirmed with blood tests before any conclusions are drawn.

Common Causes of Glucose in Urine

The most common cause is diabetes mellitus, but glucosuria also occurs in gestational diabetes, physiological glycosuria of pregnancy, renal glucosuria, Fanconi syndrome, and as an intentional effect of SGLT2 inhibitor therapy.

The most frequently identified cause of glucosuria in the UK is diabetes mellitus, encompassing both Type 1 and Type 2 diabetes. In these conditions, persistently elevated blood glucose levels exceed the renal threshold, resulting in glucose appearing in the urine. Gestational diabetes — a form of glucose intolerance that develops during pregnancy — is another important cause, and routine urine testing during antenatal appointments is partly designed to detect this.

Physiological glycosuria of pregnancy is also recognised as a normal variant: the renal threshold for glucose falls during pregnancy, so some women excrete glucose in their urine despite having normal blood glucose levels. This is distinct from gestational diabetes and does not in itself indicate a problem, though it should prompt appropriate assessment to exclude gestational diabetes.

Glucosuria can also occur in the absence of elevated blood glucose, a condition known as renal glucosuria. This is caused by a reduced renal threshold for glucose reabsorption, often due to a defect in the sodium–glucose co-transporter (SGLT2) in the proximal tubule of the kidney. Renal glucosuria is generally a benign, inherited condition and does not require treatment in most cases.

Other causes include:

• Fanconi syndrome — a disorder of proximal tubule function that impairs reabsorption of multiple substances, including glucose, phosphate, and amino acids

• Proximal tubular dysfunction due to drug- or toxin-induced tubulopathy, or tubulointerstitial disease — it is proximal tubular damage specifically, rather than chronic kidney disease or acute kidney injury in general, that leads to glucosuria

• Certain medications, including SGLT2 inhibitors (such as dapagliflozin, empagliflozin, and canagliflozin), which are deliberately prescribed to lower blood glucose by promoting urinary glucose excretion. Patients taking these medicines should be aware that glucosuria is an expected and intentional effect, but they should also be counselled about the risk of diabetic ketoacidosis (DKA) — including euglycaemic DKA (where blood glucose may not be markedly elevated) — and should follow sick-day guidance (see the Treatment section below). Do not stop SGLT2 inhibitor treatment without first seeking medical advice.

• Stress hyperglycaemia — a transient rise in blood glucose during acute illness or physiological stress

In healthy individuals with normal renal function, dietary factors alone are very unlikely to cause glucosuria. Identifying the precise cause requires clinical context and further testing.

How Glucosuria Is Diagnosed in the UK

Glucosuria is initially detected by urine dipstick, then confirmed with blood tests — fasting plasma glucose (≥7.0 mmol/L diagnostic), HbA1c (≥48 mmol/mol diagnostic), or a 75 g OGTT for gestational diabetes — in line with NICE guidance.

In UK clinical practice, glucosuria is most commonly first detected using a urine dipstick test, a simple, rapid, and inexpensive point-of-care investigation. The dipstick contains a glucose oxidase reagent that produces a colour change in the presence of glucose. Results are reported semi-quantitatively (e.g., trace, 1+, 2+, 3+). Whilst a useful screening tool, dipstick testing is not definitive: very dilute urine or high concentrations of ascorbic acid (vitamin C) can reduce the apparent glucose reading, potentially producing a false negative. Bacterial metabolism in a delayed or poorly stored sample can also lower the apparent glucose level.

If glucosuria is detected on dipstick, the next step in line with NICE guidance is to assess blood glucose levels. This typically involves:

• Fasting plasma glucose — a blood test taken after at least eight hours without food; a result of ≥7.0 mmol/L is diagnostic of diabetes (if confirmed on a second occasion, or if symptoms are present)

• HbA1c (glycated haemoglobin) — a measure of average blood glucose over the preceding two to three months; a result of ≥48 mmol/mol (6.5%) is diagnostic of diabetes in most adults

• Random plasma glucose — a result of ≥11.1 mmol/L in the presence of symptoms of hyperglycaemia is diagnostic of diabetes

• Oral glucose tolerance test (OGTT) — a 75 g OGTT is the recommended test for diagnosing gestational diabetes (per NICE NG3) and may also be used in selected non-pregnant adults when HbA1c or fasting plasma glucose results are inconclusive

It is important to note that HbA1c should not be used to diagnose diabetes in pregnancy, in suspected Type 1 diabetes, or in individuals with certain haemoglobinopathies or haematological conditions that affect red cell turnover. In these situations, plasma glucose measurements and/or OGTT are used instead.

If blood glucose results are within the normal range but glucosuria persists, renal glucosuria may be suspected. In this scenario, a GP may arrange further renal function tests, including serum creatinine, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (ACR) — the NICE-preferred test for detecting kidney involvement (per NICE NG203). If symptoms of hyperglycaemia are present alongside glucosuria, capillary blood ketones should be checked promptly to exclude DKA. A mid-stream urine (MSU) sample should be sent for culture only if a urinary tract infection is clinically suspected, as UTI does not typically cause a false positive for glucose on dipstick. All investigations should be interpreted alongside the patient's full clinical history and any relevant symptoms.

When to See a GP About Glucose in Your Urine

Contact your GP promptly if glucose is found in your urine; seek same-day assessment via NHS 111 or A&E if symptoms suggest DKA or Type 1 diabetes, particularly in children.

If glucose is detected in your urine — whether through a home testing kit, a pharmacy check, or a result communicated from a healthcare setting — it is advisable to contact your GP promptly for further assessment. Whilst glucosuria is not always a sign of serious illness, it should never be dismissed without proper investigation, as it may be an early indicator of diabetes or another underlying condition.

You should seek a GP appointment as soon as possible if you notice glucose in your urine alongside any of the following symptoms:

• Increased thirst (polydipsia) or a persistently dry mouth

• Frequent urination (polyuria), particularly at night

• Unexplained weight loss

• Fatigue or lack of energy that is unusual for you

• Blurred vision

• Slow-healing wounds or recurrent infections

These symptoms, in combination with glucosuria, may suggest undiagnosed or poorly controlled diabetes and warrant urgent blood glucose testing.

Seek same-day medical assessment — by contacting your GP urgently or calling NHS 111 — if you or someone you care for has glucosuria with symptoms that may suggest Type 1 diabetes or diabetic ketoacidosis (DKA), such as nausea or vomiting, abdominal pain, rapid or deep breathing, confusion, or signs of dehydration. This is particularly important in children and young people, in whom Type 1 diabetes can present rapidly and deteriorate quickly. Call 999 or go to A&E immediately if someone is severely unwell, unconscious, or breathing abnormally.

If you are pregnant and glucose is found in your urine at an antenatal appointment, your midwife or obstetrician will arrange appropriate follow-up. In line with NICE NG3, a finding of glucosuria of 2+ or more on one occasion, or 1+ on two or more occasions, should prompt consideration of testing for gestational diabetes, as this carries specific risks for both mother and baby.

In the absence of symptoms, a single trace of glucose on a dipstick — particularly in a dilute or post-meal urine sample — may not be clinically significant, but it should still be discussed with a healthcare professional. Repeated findings of glucosuria across multiple urine samples are more likely to be meaningful and should always prompt further investigation. Do not attempt to self-diagnose or self-treat based on a urine test result alone.

Treatment and Next Steps After a Positive Result

Treatment depends on the underlying cause: Type 2 diabetes is managed with lifestyle changes and metformin (NICE NG28); Type 1 requires insulin therapy; SGLT2 inhibitor-related glucosuria needs no additional treatment but requires DKA awareness and sick-day guidance.

The management of glucosuria depends entirely on its underlying cause, which is why thorough investigation is essential before any treatment is initiated. If glucosuria is confirmed to be secondary to Type 2 diabetes, NICE guidance (NG28) recommends a structured approach beginning with lifestyle modification — including dietary changes, increased physical activity, and weight management — alongside regular monitoring of HbA1c. Pharmacological treatment, typically starting with metformin (if tolerated and renal function permits), may be introduced if lifestyle measures alone are insufficient to achieve glycaemic targets. Alternative first-line agents are available if metformin is not tolerated or is contraindicated.

For Type 1 diabetes, management centres on insulin therapy, which must be carefully titrated to maintain blood glucose within a safe range. Patients are supported by a multidisciplinary diabetes team, including specialist nurses, dietitians, and diabetologists, in line with NHS diabetes care pathways.

If glucosuria is caused by SGLT2 inhibitor therapy (e.g., dapagliflozin, empagliflozin, or canagliflozin), the finding is an expected and intentional pharmacological effect. These medicines work by blocking SGLT2 receptors in the renal proximal tubule, thereby reducing glucose reabsorption and promoting its excretion in urine. No additional treatment is required for the glucosuria itself. However, patients should be aware of the following important safety information, in line with MHRA guidance:

• There is an increased risk of diabetic ketoacidosis (DKA), including euglycaemic DKA (where blood glucose may not be markedly elevated). Seek urgent medical attention if you develop nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing, confusion, or unusual fatigue.

• Sick-day guidance: SGLT2 inhibitors should generally be withheld during acute illness, significant dehydration, or before surgical procedures (typically at least three days before elective surgery). Always follow the advice of your prescribing clinician.

• Maintain adequate fluid intake to reduce the risk of dehydration and urinary tract infections.

• There is an increased risk of genital mycotic infections (thrush) and urinary tract infections associated with persistently glucose-rich urine.

• Do not stop your SGLT2 inhibitor or any other diabetes medicine without first seeking medical advice.

• Suspected adverse drug reactions to any medicine can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

For renal glucosuria with normal blood glucose and no evidence of broader tubular dysfunction, reassurance and monitoring are usually sufficient. Patients should be informed that this is a benign condition and does not require specific treatment, though periodic review of renal function is sensible.

Managing the Underlying Condition: NHS Guidance

Long-term management includes HbA1c monitoring every three to six months, blood pressure and lipid checks, renal function tests (eGFR and urine ACR per NICE NG203), retinal screening, and access to NHS structured education programmes such as DESMOND and DAFNE.

Long-term management of conditions associated with glucosuria — particularly diabetes — is well-supported by NHS and NICE frameworks. For individuals with non-diabetic hyperglycaemia (prediabetes) — typically defined as an HbA1c of 42–47 mmol/mol or a fasting plasma glucose of 5.5–6.9 mmol/L — the NHS offers access to the NHS Diabetes Prevention Programme (NHS DPP), a structured behavioural intervention designed to support weight loss, improve diet quality, and increase physical activity. Evidence suggests this programme can significantly reduce the risk of progression to Type 2 diabetes.

Ongoing monitoring is central to safe diabetes management. In line with NICE NG28, people with Type 2 diabetes should have their HbA1c checked every three to six months until levels are stable, then every six months thereafter. Regular review should also include:

• Blood pressure monitoring — hypertension is a common comorbidity

• Lipid profile assessment — to manage cardiovascular risk

• Renal function tests — including eGFR and urine albumin-to-creatinine ratio (ACR), which is the NICE-preferred measure for detecting diabetic kidney disease (per NICE NG203)

• Foot examination — to detect early signs of diabetic neuropathy or peripheral vascular disease

• Retinal screening — offered annually through the NHS Diabetic Eye Screening Programme

For patients managing diabetes at home, self-monitoring of blood glucose may be recommended depending on treatment type and individual circumstances. The NHS also provides access to structured education programmes such as DESMOND (for Type 2 diabetes) and DAFNE (for Type 1 diabetes), which equip patients with the knowledge and skills to manage their condition effectively.

If you have been told you have glucose in your urine, the most important message is that early investigation and appropriate management can significantly reduce the risk of long-term complications. Engaging with your GP, practice nurse, or diabetes team at the earliest opportunity is strongly encouraged. If you experience any side effects from your medicines, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions